This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends for 2025, the eligibility of life sciences companies for qualified small business stock, what life sciences companies need to know about brands, double-patenting jeopardy, and life sciences venture financings for clients across 2H 2023 and 1H 2024. The newsletter also includes details on the firm’s inaugural Biotech Summit and 29th Annual Phoenix Conference, technical writing and IPO documentation offerings for life sciences clients, 2024 LaunchBio NextGen VC Forums, the Patents and Innovations Learning Library for in-house IP counsel, the latest episodes of the NextGen VC Podcast focused on life sciences investing, and a call for applications from MedTech Innovator and BioTools Innovator, as well as select life sciences client highlights.
Please see full publication below for more information.
